Abstract
BackgroundIncreasing evidence suggests the potential of Epstein-Barr virus (EBV) vaccination in preventing multiple sclerosis (MS). We aimed to explore the cost-effectiveness of a hypothetical EBV vaccination to prevent MS in...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have